首页 | 本学科首页   官方微博 | 高级检索  
     


Use of long-acting injectable risperidone before and throughout pregnancy in schizophrenia
Authors:Kim Sung-Wan  Kim Ki-Min  Kim Jae-Min  Shin Il-Seon  Shin Hee-Young  Yang Su-Jin  Yoon Jin-Sang
Affiliation:Department of Psychiatry, Chonnam National University Medical School, 5 Hak-dong, Dong-ku, Kwangju 501-746, Republic of Korea.
Abstract:Data on the use of long-acting injectable (LAI) risperidone, the first atypical depot antipsychotic, during pregnancy are limited. A 35-year-old woman with schizophrenia was given LAI risperidone before and throughout her pregnancy. She gave birth to a female infant weighing 2230 g at 36 weeks and 6 days of pregnancy, following premature rupture of the membranes. The baby had no congenital malformation and was healthy 8 months postnatal. To our knowledge, this is the first reported use of LAI risperidone throughout an entire pregnancy. In this paper, we discuss the rationale and problems of LAI risperidone use in pregnancy, based on a literature review.
Keywords:LAI risperidone, long-acting injectable risperidone   APGAR, activity, pulse, grimace, appearance, respiration
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号